curasafehealthcare.com
  • Home
  • About
  • Services
  • Therapeutic Areas
  • Careers
  • Latest News
  • Contact Us
Select Page

An Online Tailored Cognitive Therapy-Based Intervention for Depression in Multiple Sclerosis: ACTION-MS Online

by palligoelme@gmail.com | Oct 15, 2026 | Clinical Trials

​ Conditions: Depression and Anxiety Symptoms; Multiple Sclerosis Interventions: Device: ACTION-MS website – an 8-week cognitive behavioural therapy intervention for depression.; Device: The ‘Health and Wellbeing in MS’ website Sponsors: University...

Improved Breast Enlargement Using the Subject’s Own Fat Tissue

by palligoelme@gmail.com | Oct 15, 2026 | Clinical Trials

​ Conditions: Breast Augmentation Interventions: Device: An injectable, biodegradable hydrogel, in reconstitution medium; Device: Reconstitution medium Sponsors: 4Tissue; Xper Research Recruiting Conditions: Breast Augmentation Interventions: Device: An injectable,...

Diaphragm Hibernation and Its Driving Factors in Mechanically Ventilated ICU Patients

by palligoelme@gmail.com | Oct 15, 2026 | Clinical Trials

​ Conditions: Diaphragm Dysfunction; Weaning Invasive Mechanical Ventilation; Respiratory Failure, ICU Sponsors: Radboud University Medical Center Not yet recruiting Conditions: Diaphragm Dysfunction; Weaning Invasive Mechanical Ventilation; Respiratory Failure, ICU...

Real-world Clinical Effectiveness & Safety LV009, an in Vivo CAR-T for the Treatment of Hematologic Cancers, Auto-immune Diseases & HLA/ AAV Sensitization.

by palligoelme@gmail.com | Oct 14, 2026 | Clinical Trials

​ Conditions: HLA/AAV Sensitization; Auto-immune Diseases; Hematologic Cancers Interventions: Genetic: LV009 Sponsors: Healthy Malaysia Association Not yet recruiting Conditions: HLA/AAV Sensitization; Auto-immune Diseases; Hematologic Cancers Interventions: Genetic:...

MRG003 Added to Ongoing Treatment After Progression in EGFR-Positive Advanced Thyroid Cancer

by palligoelme@gmail.com | Oct 14, 2026 | Clinical Trials

​ Conditions: Thyroid Cancer; Tumor; Advanced Thyroid Carcinoma Interventions: Drug: Becotatug Vedotin (MRG003); Drug: Lenvatinib; Biological: Anti-PD-1 Inhibitor (Continuation of Prior Treatment) Sponsors: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University...
« Older Entries
Next Entries »

Recent Posts

  • NIR-II Fluorescence-Guided Hepatectomy Using ICG-Cisplatin Nanoprobes for HCC
  • Climate Change Trends and Their Impact on the Seasonal Upper Respiratory Tract Disease Burden
  • Music Therapy for Character Development and Social Adaptation Among Rural Left-Behind Children
  • Maternal and Cord Blood MST1 Levels in Gestational Diabetes Mellitus
  • Fufang Tongluo Decoction as an Adjunct to Aspirin and Atorvastatin for Ischemic Moyamoya Disease

Recent Comments

No comments to show.

Curasafe healthcare solutions Pvt. Ltd. provides comprehensive services including safety program oversight, risk management, and regulatory compliance.

Important Links

  • Home
  • Contact Us
Connect With Us

Contact


711, Shivalik Satyamev, Bopal Ambli Junction, Bopal, Ahmedabad, Daskroi, Gujarat, India, 380058.


info@curasafehealthcare.com



(+91) 97803 81065

Copyright © 2025 Curasafehealthcare ®